Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating substantial results in the treatment of type 2 diabetes. This man-made peptide duplicates the actions of naturally occurring GLP-1, a https://myfirstbookmark.com/story20852244/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes